2023
Chaplin, M., Bresnahan, R., Fleeman, N., Mahon, J., Houten, R., Beale, S., . . . Munot, P. (2023). Correction: Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15.. PharmacoEconomics - open, 7(6), 1015. doi:10.1007/s41669-023-00462-7DOI: 10.1007/s41669-023-00462-7
Chaplin, M., Bresnahan, R., Fleeman, N., Mahon, J., Houten, R., Beale, S., . . . Munot, P. (2023). Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15. PharmacoEconomics - Open. doi:10.1007/s41669-023-00439-6DOI: 10.1007/s41669-023-00439-6
Chaplin, M., & Dwan, K. (2023). Cluster‐randomized controlled trials: A tutorial. Cochrane Evidence Synthesis and Methods, 1(7). doi:10.1002/cesm.12024DOI: 10.1002/cesm.12024
Bresnahan, R., Houten, R., Greenhalgh, J., Nevitt, S., Mahon, J., Beale, S., . . . Chaplin, M. (2023). Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.. PharmacoEconomics - open. doi:10.1007/s41669-023-00408-zDOI: 10.1007/s41669-023-00408-z
Greenhalgh, J., Mahon, J., Bryning, S., Chaplin, M., Beale, S., Boland, A., . . . Basu, B. (2023). Durvalumab with gemcitabine and cisplatin for treating unresectable or advanced biliary tract cancer [ID4031]: Durvalumab with gemcitabine and cisplatin for treating unresectable or advanced biliary tract cancer [ID4031]. Retrieved from https://www.nice.org.uk/guidance/gid-ta10920/documents/committee-papers
Houten, R., Fleeman, N., Mahon, J., Chaplin, M., Edwards, K., Beale, S., . . . Palmieri, C. (2023). Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN. doi:10.1007/s41669-023-00405-2DOI: 10.1007/s41669-023-00405-2
Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation. (Journal article)
Bresnahan, R., Duarte, R., Mahon, J., Beale, S., Chaplin, M., Bhattacharyya, D., . . . Boland, A. (2023). Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation.. Health technology assessment (Winchester, England), 27(10), 1-115. doi:10.3310/kgju3398DOI: 10.3310/kgju3398
2022
Fox, T., Furnival-Adams, J., Chaplin, M., Napier, M., & Olanga, E. A. (2022). House modifications for preventing malaria.. The Cochrane database of systematic reviews, 10, CD013398. doi:10.1002/14651858.cd013398.pub4DOI: 10.1002/14651858.cd013398.pub4
Smith, R., Villanueva, G., Probyn, K., Sguassero, Y., Ford, N., Orrell, C., . . . Hine, P. (2022). Accuracy of measures for antiretroviral adherence in people living with HIV. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (7). doi:10.1002/14651858.CD013080.pub2DOI: 10.1002/14651858.CD013080.pub2
Pillay, S., Steingart, K. R., Davies, G. R., Chaplin, M., De Vos, M., Schumacher, S. G., . . . Theron, G. (2022). Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (5). doi:10.1002/14651858.CD014841.pub2DOI: 10.1002/14651858.CD014841.pub2
Naude, C. E., Brand, A., Schoonees, A., Nguyen, K. A., Chaplin, M., & Volmink, J. (2022). Low-carbohydrate versus balanced-carbohydrate diets for reducing weight and cardiovascular risk.. The Cochrane database of systematic reviews, 1, CD013334. doi:10.1002/14651858.cd013334.pub2DOI: 10.1002/14651858.cd013334.pub2
2021
Nathavitharana, R. R., Lederer, P., Chaplin, M., Bjerrum, S., Steingart, K. R., & Shah, M. (2021). Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV.. The Cochrane database of systematic reviews, 8, CD014641. doi:10.1002/14651858.cd014641DOI: 10.1002/14651858.cd014641
Pillay, S., Davies, G. R., Chaplin, M., De Vos, M., Schumacher, S. G., Warren, R., . . . Theron, G. (n.d.). Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin. Cochrane Database of Systematic Reviews, 2021(6). doi:10.1002/14651858.cd014841DOI: 10.1002/14651858.cd014841
Gleave, K., Lissenden, N., Chaplin, M., Choi, L., & Ranson, H. (2021). Piperonyl butoxide (PBO) combined with pyrethroids in insecticide-treated nets to prevent malaria in Africa. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (5). doi:10.1002/14651858.CD012776.pub3DOI: 10.1002/14651858.CD012776.pub3
Anton-Vazquez, V., Hine, P., Krishna, S., Chaplin, M., & Planche, T. (2021). Rapid versus standard antimicrobial susceptibility testing to guide treatment of bloodstream infection.. The Cochrane database of systematic reviews, 5, CD013235. doi:10.1002/14651858.cd013235.pub2DOI: 10.1002/14651858.cd013235.pub2
Greenhalgh, J., Boland, A., Bates, V., Vecchio, F., Dundar, Y., Chaplin, M., & Green, J. A. (2021). First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (3). doi:10.1002/14651858.CD010383.pub3DOI: 10.1002/14651858.CD010383.pub3
Chaplin, M. (2021, March 11). Improving the Reporting of Pharmacogenetic Studies to Facilitate Evidence Synthesis: Anti-Tuberculosis Drug-Related Toxicity as an Example.
Singh, B., Ryan, H., Kredo, T., Chaplin, M., & Fletcher, T. (2021). Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (2). doi:10.1002/14651858.CD013587.pub2DOI: 10.1002/14651858.CD013587.pub2
Weeratunga, P., Bancone, G., Ochodo, E. A., Pant, S., Thapa, J., & Chaplin, M. (n.d.). Glucose-6-phosphate dehydrogenase deficiency near-patient tests for tafenoquine or primaquine use with Plasmodium vivax malaria. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd013861DOI: 10.1002/14651858.cd013861
2020
Stainthorpe, A., Fleeman, N., Houten, R., Chaplin, M., Boland, A., Beale, S., . . . Syndikus, I. (2020). Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN, 4(4), 563-574. doi:10.1007/s41669-020-00203-0DOI: 10.1007/s41669-020-00203-0
Chaplin, M., Kirkham, J. J., Dwan, K., Sloan, D. J., Davies, G., & Jorgensen, A. L. (2020). STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline. PLOS MEDICINE, 17(9). doi:10.1371/journal.pmed.1003344DOI: 10.1371/journal.pmed.1003344
Jullien, S., Dissanayake, H. A., & Chaplin, M. (2020). Rapid diagnostic tests for plague.. The Cochrane database of systematic reviews, 6, CD013459. doi:10.1002/14651858.cd013459.pub2DOI: 10.1002/14651858.cd013459.pub2
Strauss, J. A., Ranasinghe, C., Cowley, E., Schwingshackl, L., Shepherd, S. O., Chaplin, M., & Garner, P. (n.d.). High-intensity interval training for reducing cardiometabolic syndrome in healthy but sedentary populations. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd013617DOI: 10.1002/14651858.cd013617
Singh, B., Ryan, H., Kredo, T., Chaplin, M., & Fletcher, T. (n.d.). Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd013587DOI: 10.1002/14651858.cd013587
Ixekizumab for treating axial spondyloarthritis after NSAIDs [ID1532] (Report)
Greenhalgh, J., Fleeman, N., Houten, R., Chaplin, M., Beale, S., Boland, A., . . . Goodson, N. (2020). Ixekizumab for treating axial spondyloarthritis after NSAIDs [ID1532]: Ixekizumab for treating axial spondyloarthritis after NSAIDs[ID1532]. Retrieved from https://www.liverpool.ac.uk/population-health/staff/janette-greenhalgh/
Duarte, R., Stainthorpe, A., Greenhalgh, J., Richardson, M., Nevitt, S., Mahon, J., . . . Takwoingi, Y. (2020). Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 24(3), 1-+. doi:10.3310/hta24030DOI: 10.3310/hta24030
Fleeman, N., Houten, R., Bagust, A., Richardson, M., Beale, S., Boland, A., . . . Shenoy, A. (2020). Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 24(2), 1-+. doi:10.3310/hta24020DOI: 10.3310/hta24020
2019
Fleeman, N., Houten, R., Chaplin, M., Beale, S., Boland, A., Dundar, Y., . . . Shenoy, A. (2019). A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine. BMC CANCER, 19(1). doi:10.1186/s12885-019-6369-7DOI: 10.1186/s12885-019-6369-7
Duarte, R., Stainthorpe, A., Mahon, J., Greenhalgh, J., Richardson, M., Nevitt, S., . . . Takwoingi, Y. (2019). Lead-I ECG for detecting atrial fibrillation in patients attending primary care with an irregular pulse using single-time point testing: A systematic review and economic evaluation. PLOS ONE, 14(12). doi:10.1371/journal.pone.0226671DOI: 10.1371/journal.pone.0226671
Fleeman, N., Bagust, A., Duarte, R., Richardson, M., Nevitt, S., Boland, A., . . . Thorp, N. (2019). Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS-OPEN, 3(3), 293-302. doi:10.1007/s41669-018-0114-zDOI: 10.1007/s41669-018-0114-z
Pembrolizumab for untreated recurrent or metastatic squamous cell carcinoma of the head and neck (Report)
Greenhalgh, J., Mahon, J., Chaplin, M., Nevitt, S., Boland, A., Beale, S., . . . Shaw, R. (2019). Pembrolizumab for untreated recurrent or metastatic squamous cell carcinoma of the head and neck: Pembrolizumab for untreated recurrent or metastatic squamous cell carcinoma of the head and neck (17/56/06). NICE website. Retrieved from https://www.nice.org.uk/guidance/gid-ta10181/documents/committee-papers
Richardson, M., Kirkham, J. J., Dwan, K. M., Sloan, D. J., Davies, G., & Jorgensen, A. (2019). Protocol for the development of the STrengthening the Reporting Of Pharmacogenetic Studies (STROPS) guideline: checklist of items for reporting pharmacogenetic studies. BMJ OPEN, 9(7). doi:10.1136/bmjopen-2019-030212DOI: 10.1136/bmjopen-2019-030212
Atezolizumab for untreated, locally advanced or metastatic, triple negative breast cancer (Report)
Greenhalgh, J., Mahon, J., Chaplin, M., Beale, S., Boland, A., Lambe, T., . . . Palmieri, C. (2019). Atezolizumab for untreated, locally advanced or metastatic, triple negative breast cancer: Atezolizumab for untreated, locally advanced or metastatic, triple negative breast cancer (128748). NICE website. Retrieved from https://www.nice.org.uk/guidance/gid-ta10433/documents/committee-papers
Naude, C. E., Schoonees, A., Nguyen, K. A., Senekal, M., Young, T., Garner, P., . . . Volmink, J. (n.d.). Low carbohydrate versus balanced carbohydrate diets for reducing weight and cardiovascular risk. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd013334DOI: 10.1002/14651858.cd013334
Richardson, M., Kirkham, J., Dwan, K., Sloan, D. J., Davies, G., & Jorgensen, A. L. (2019). NAT2 variants and toxicity related to anti-tuberculosis agents: a systematic review and meta-analysis. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 23(3), 293-305. doi:10.5588/ijtld.18.0324DOI: 10.5588/ijtld.18.0324
Richardson, M., Kirkham, J., Dwan, K., Sloan, D., Davies, G., & Jorgensen, A. (2019). Association of variants within the <i>GST</i> and other genes with anti-tubercular agents related toxicity: a systematic review and meta-analysis. doi:10.1101/515817DOI: 10.1101/515817
Macfarlane, C. L., Budhathoki, S. S., Johnson, S., Richardson, M., & Garner, P. (2019). Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (1). doi:10.1002/14651858.CD003753.pub4DOI: 10.1002/14651858.CD003753.pub4
2018
Anton-Vazquez, V., Hine, P., Krishna, S., Richardson, M., & Planche, T. (n.d.). Rapid versus standard antibiotic susceptibility testing for treating bloodstream infections. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd013235DOI: 10.1002/14651858.cd013235
Gleave, K., Lissenden, N., Richardson, M., Choi, L., & Ranson, H. (2018). Piperonyl butoxide (PBO) combined with pyrethroids in insecticide-treated nets to prevent malaria in Africa.. The Cochrane database of systematic reviews, 11, CD012776. doi:10.1002/14651858.cd012776.pub2DOI: 10.1002/14651858.cd012776.pub2
Richardson, M., Kirkham, J., Dwan, K., Sloan, D. J., Davies, G., & Jorgensen, A. L. (2018). <i>CYP</i> genetic variants and toxicity related to anti-tubercular agents: a systematic review and meta-analysis. SYSTEMATIC REVIEWS, 7. doi:10.1186/s13643-018-0861-zDOI: 10.1186/s13643-018-0861-z
Osimertinib for untreated epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer (Report)
Fleeman, N., Mahon, J., Chaplin, M., Boland, A., Beale, S., De Sousa Rego Vieira Duarte, R., . . . Green, J. (2018). Osimertinib for untreated epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer: Osimertinib for untreated epidermal growth factor receptor (EGFR) mutation-positive non- small-cell lung cancer (17/141/08). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta621/documents/committee-papers
Pryce, J., Richardson, M., & Lengeler, C. (2018). Insecticide-treated nets for preventing malaria. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (11). doi:10.1002/14651858.CD000363.pub3DOI: 10.1002/14651858.CD000363.pub3
Pryce, J., Richardson, M., & Lengeler, C. (2018). Insecticide-treated nets for preventing malaria.. The Cochrane database of systematic reviews, 11, CD000363. doi:10.1002/14651858.cd000363.pub3DOI: 10.1002/14651858.cd000363.pub3
Pryce, J., Choi, L., Richardson, M., & Malone, D. (2018). Insecticide space spraying for preventing malaria transmission. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (11). doi:10.1002/14651858.CD012689.pub2DOI: 10.1002/14651858.CD012689.pub2
Fleeman, N., Stainthorpe, A., Houten, R., Chaplin, M., Boland, A., Beale, S., . . . Isabel, S. (2018). Brentuximab vedotin for treating relapsed or refractory CD30-positive cutaneous T-cell lymphoma (17/56/12): Brentuximab vedotin for treating relapsed or refractory CD30- positive cutaneous T-cell lymphoma (17/56/12). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta577/documents/committee-papers
Stainthorpe, A., Greenhalgh, J., Bagust, A., Richardson, M., Boland, A., Beale, S., . . . Palmer, D. (2018). Paclitaxel as Albumin-Bound Nanoparticles with Gemcitabine for Untreated Metastatic Pancreatic Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 36(10), 1153-1163. doi:10.1007/s40273-018-0646-1DOI: 10.1007/s40273-018-0646-1
Yotsu, R. R., Richardson, M., & Ishii, N. (2018). Drugs for treating Buruli ulcer (<i>Mycobacterium ulcerans</i> disease). COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (8). doi:10.1002/14651858.CD012118.pub2DOI: 10.1002/14651858.CD012118.pub2
Eshun-Wilson, I., Okwen, M. P., Richardson, M., & Bicanic, T. (2018). Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (7). doi:10.1002/14651858.CD009012.pub3DOI: 10.1002/14651858.CD009012.pub3
Milligan, R., Paul, M., Richardson, M., & Neuberger, A. (2018). Vaccines for preventing typhoid fever (Review). COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (5). doi:10.1002/14651858.CD001261.pub4DOI: 10.1002/14651858.CD001261.pub4
Richardson, M., Garner, P., & Donegan, S. (2018). Interpretation of subgroup analyses in systematic reviews: A tutorial. Clinical Epidemiology and Global Health. doi:10.1016/j.cegh.2018.05.005DOI: 10.1016/j.cegh.2018.05.005
Aslam, R. W., Bates, V., Dundar, Y., Hounsome, J., Richardson, M., Krishan, A., . . . Sikdar, S. (2018). A systematic review of the diagnostic accuracy of automated tests for cognitive impairment. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 33(4), 561-575. doi:10.1002/gps.4852DOI: 10.1002/gps.4852
Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating Pancreatic Cancer After Gemcitabine: An Evidence Review Group Perspective of a NICE Single Technology Appraisal (Journal article)
Fleeman, N., Abdulla, A., Bagust, A., Beale, S., Richardson, M., Stainthorpe, A., . . . Palmer, D. (2018). Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating Pancreatic Cancer After Gemcitabine: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS, 36(3), 289-299. doi:10.1007/s40273-017-0592-3DOI: 10.1007/s40273-017-0592-3
Maia, M. F., Kliner, M., Richardson, M., Lengeler, C., & Moore, S. J. (2018). Mosquito repellents for malaria prevention. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (2). doi:10.1002/14651858.CD011595.pub2DOI: 10.1002/14651858.CD011595.pub2
Richardson, M., Kirkham, J., Dwan, K., Sloan, D., Davies, G., & Jorgensen, A. (2018). Development of reporting guidelines for pharmacogenetic studies to facilitate evidence synthesis. In GENETIC EPIDEMIOLOGY Vol. 42 (pp. 727). Retrieved from https://www.webofscience.com/
Gleave, K., Lissenden, N., Richardson, M., Choi, L., & Ranson, H. (2018). Piperonyl butoxide (PBO) combined with pyrethroids in insecticide-treated nets to prevent malaria in Africa. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (11). doi:10.1002/14651858.C0012776.pub2DOI: 10.1002/14651858.C0012776.pub2
2017
Fleeman, N., Bagust, A., Duarte, R., Chaplin, M., Nevitt, S., Boland, A., . . . Thorp, N. (n.d.). Eribulin for treating locally advanced or metastatic breast cancer after one prior chemotherapy regimen (ID1072). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta515/documents/committee-papers
Fleeman, N., Bagust, A., Boland, A., Beale, S., Richardson, M., Krishan, A., . . . Payne, M. (2017). Talimogene Laherparepvec for Treating Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PHARMACOECONOMICS, 35(10), 1035-1046. doi:10.1007/s40273-017-0504-6DOI: 10.1007/s40273-017-0504-6
Gleave, K., Lissenden, N., Richardson, M., & Ranson, H. (n.d.). Piperonyl butoxide (PBO) combined with pyrethroids in long-lasting insecticidal nets (LLINs) to prevent malaria in Africa. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd012776DOI: 10.1002/14651858.cd012776
Uthman, O. A., Graves, P. M., Saunders, R., Gelband, H., Richardson, M., & Garner, P. (2017). Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies. MALARIA JOURNAL, 16. doi:10.1186/s12936-017-1989-3DOI: 10.1186/s12936-017-1989-3
Sorafenib and lenvatinib for treating advanced or metastatic thyroid cancer (Report)
Greenhalgh, J. (n.d.). Sorafenib and lenvatinib for treating advanced or metastatic thyroid cancer (ID1059). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta535/documents/committee-papers
Richardson, M. H., Kirkham, J., Dwan, K., Sloan, D., Davies, G., & Jorgensen, A. (2017). Influence of genetic variants on toxicity to anti-tubercular agents: a systematic review and meta-analysis (protocol). Systematic Reviews. doi:10.1186/s13643-017-0533-4DOI: 10.1186/s13643-017-0533-4
Greenhalgh, J. (n.d.). Nab-paclitaxel with gemcitabine for 1st line metastatic pancreatic adenocarcinoma (ID1058). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta476/documents/committee-papers
Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer (Report)
Greenhalgh, J., Bagust, A., Stainthorpe, A., Chaplin, M., Boland, A., De Sousa Rego Vieira Duarte, R., . . . Palmer, D. (2017). Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer: Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer (14/90/01). NICE website. Retrieved from https://www.nice.org.uk/guidance/ta476/documents/committee-papers
Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after platinum-based chemotherapy (Report)
Greenhalgh, J. (n.d.). Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after platinum-based chemotherapy (ID970). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta520/documents/committee-papers
Beale, S., Mahon, J., Nevitt, S., Boland, A., Greenhalgh, J., Richardson, M., . . . Green, J. (2017). Atezolizumab for the treatment of people with locally advanced or metastatic non-small lung cancer whose disease has progressed after chemotherapy (ID970).
Greenhalgh, J., Stainthorpe, S., Richardson, M., Duarte, R., Boland, A., Kotas, E., . . . Green, J. (2017). Crizotinib for treating ROS1positive advanced non-small cell lung cancer (D1098).
2016
Greenhalgh, J. (n.d.). Palbociclib for treating metastatic, hormone receptor-positive, HER2-negative breast cancer (ID915). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta495/documents/committee-papers-2
Automated tests for diagnosing and monitoring cognitive impairment: a diagnostic accuracy review (Journal article)
Aslam, R. W., Bates, V., Dundar, Y., Hounsome, J., Richardson, M., Krishan, A., . . . Robinson, L. (2016). Automated tests for diagnosing and monitoring cognitive impairment: a diagnostic accuracy review. Health Technology Assessment, 20(77). doi:10.3310/hta20770DOI: 10.3310/hta20770
Aslam, R. W., Bates, V., Dundar, Y., Hounsome, J., Richardson, M., Krishan, A., . . . Robinson, L. (2016). Automated tests for diagnosing and monitoring cognitive impairment: a diagnostic accuracy review. Health technology assessment (Winchester, England), 20(77), 1-74.
GenoType® MTBDR<i>sl</i> assay for resistance to second-line anti-tuberculosis drugs (Journal article)
Theron, G., Peter, J., Richardson, M., Warren, R., Dheda, K., & Steingart, K. R. (2016). GenoType® MTBDR<i>sl</i> assay for resistance to second-line anti-tuberculosis drugs. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (9). doi:10.1002/14651858.CD010705.pub3DOI: 10.1002/14651858.CD010705.pub3
Greenhalgh, J. (n.d.). Eribulin for locally advanced or metastatic breast cancer (ID964). NICE Website. Retrieved from https://www.nice.org.uk/guidance/gid-ta10030/documents/committee-papers
Greenhalgh, J. (n.d.). Nanoliposomal irinotecan for treating pancreatic cancer after prior treatment with gemcitabine (ID778). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta440/documents/committee-papers-2
Dundar, Y., Greenhalgh, J., Richardson, M., & Dwan, K. (2016). Pharmacological treatment of acute agitation associated with psychotic and bipolar disorder: a systematic review and meta-analysis. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 31(4), 268-285. doi:10.1002/hup.2535DOI: 10.1002/hup.2535
Integrated management of childhood illness (IMCI) strategy for children under five (Journal article)
Gera, T., Shah, D., Garner, P., Richardson, M., & Sachdev, H. S. (2016). Integrated management of childhood illness (IMCI) strategy for children under five. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (6). doi:10.1002/14651858.CD010123.pub2DOI: 10.1002/14651858.CD010123.pub2
Kelly, C., Gaskell, K. M., Richardson, M., Klein, N., Garner, P., & MacPherson, P. (2016). Discordant Immune Response with Antiretroviral Therapy in HIV-1: A Systematic Review of Clinical Outcomes. PLOS ONE, 11(6). doi:10.1371/journal.pone.0156099DOI: 10.1371/journal.pone.0156099
Fleeman, N., Mahon, J., Bates, V., Dickson, R., Dundar, Y., Dwan, K., . . . Shaw, B. N. J. (2016). The clinical effectiveness and cost-effectiveness of heated humidified high-flow nasal cannula compared with usual care for preterm infants: systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 20(30), 1-67. doi:10.3310/hta20300DOI: 10.3310/hta20300
Cluster Randomised Trials in Cochrane Reviews: Evaluation of Methodological and Reporting Practice (Journal article)
Richardson, M., Garner, P., & Donegan, S. (2016). Cluster Randomised Trials in Cochrane Reviews: Evaluation of Methodological and Reporting Practice. PLOS ONE, 11(03), 14 pages. doi:10.1371/journal.pone.0151818DOI: 10.1371/journal.pone.0151818
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease) (Journal article)
Yotsu, R. R., Richardson, M., & Ishii, N. (n.d.). Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease). Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd012118DOI: 10.1002/14651858.cd012118
Greenhalgh, J. (n.d.). Nivolumab for treating metastatic, non-squamous, non-small-cell lung cancer after chemotherapy (ID900). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta484/documents/committee-papers
Trametinib in combination with dabrafenib for treating advanced (unresectable or metastatic) BRAF V600 mutation-positive melanoma (Report)
Greenhalgh, J., Mahon, J., Beale, S., Boland, A., Krishan, A., Chaplin, M., . . . Steven, N. (2016). Trametinib in combination with dabrafenib for treating advanced (unresectable or metastatic) BRAF V600 mutation-positive melanoma: Trametinib in combination with dabrafenib for treating advanced (unresectable or metastatic) BRAF V600 mutation-positive melanoma (12/50/01). NICE website. Retrieved from https://www.nice.org.uk/guidance/ta396/history
Fleeman, N., Bagust, A., Boland, A., Beale, S., Chaplin, M., Krishan, A., . . . Payne, M. (2016). Talimogene laherparepvec for treating metastatic melanoma: Talimogene laherparepvec for treating metastatic melanoma (14/206/04). NICE Website. Retrieved from https://www.nice.org.uk/guidance/gid-tag509/documents/committee-papers-2
2015
Health system and community level interventions for improving antenatal care coverage and health outcomes (Journal article)
Mbuagbaw, L., Medley, N., Darzi, A. J., Richardson, M., Garga, K. H., & Ongolo-Zogo, P. (2015). Health system and community level interventions for improving antenatal care coverage and health outcomes. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (12). doi:10.1002/14651858.CD010994.pub2DOI: 10.1002/14651858.CD010994.pub2
Fleeman, N., Bagust, A., Beale, S., Boland, A., Dickson, R., Dwan, K., . . . Banks, L. (2015). Dabrafenib for Treating Unresectable, Advanced or Metastatic BRAF V600 Mutation-Positive Melanoma: An Evidence Review Group Perspective. PHARMACOECONOMICS, 33(9), 893-904. doi:10.1007/s40273-015-0276-9DOI: 10.1007/s40273-015-0276-9
Pembrolizumab for treating unresectable, metastatic melanoma after progression with ipilimumab (Report)
Fleeman, N., Bagust, A., Chaplin, M., Krishan, A., Boland, A., Beale, S., . . . Payne, M. (2015). Pembrolizumab for treating unresectable, metastatic melanoma after progression with ipilimumab: Pembrolizumab for treating unresectable, metastatic melanoma after progression with ipilimumab (14/177/07). NICE Website. Retrieved from https://www.nice.org.uk/
Effects of financial incentives for treatment supporters on tuberculosis treatment outcomes in Swaziland: a pragmatic interventional study (Journal article)
Kliner, M., Canaan, M., Ndwandwe, S. Z., Busulwa, F., Welfare, W., Richardson, M., . . . Wright, J. (2015). Effects of financial incentives for treatment supporters on tuberculosis treatment outcomes in Swaziland: a pragmatic interventional study. INFECTIOUS DISEASES OF POVERTY, 4. doi:10.1186/s40249-015-0059-8DOI: 10.1186/s40249-015-0059-8
A mismatch between population health literacy and the complexity of health information: an observational study (Journal article)
Rowlands, G., Protheroe, J., Winkley, J., Richardson, M., Seed, P. T., & Rudd, R. (2015). A mismatch between population health literacy and the complexity of health information: an observational study. BRITISH JOURNAL OF GENERAL PRACTICE, 65(635), E379-E386. doi:10.3399/bjgp15X685285DOI: 10.3399/bjgp15X685285
Pembrolizumab for treating advanced melanoma in people previously untreated with ipilimumab (Report)
Greenhalgh, J., Mahon, J., Chaplin, M., Krishan, A., Aslam, R., Beale, S., . . . Payne, M. (2015). Pembrolizumab for treating advanced melanoma in people previously untreated with ipilimumab: Pembrolizumab for treating advanced melanoma in people previously untreated with ipilimumab (14/177/06). NICE website. Retrieved from https://www.nice.org.uk/guidance/TA366/documents/committee-papers
Mosquito repellents for malaria prevention (Journal article)
Maia, M. F., Kliner, M., Richardson, M., Lengeler, C., & Moore, S. J. (n.d.). Mosquito repellents for malaria prevention. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd011595DOI: 10.1002/14651858.cd011595
Edoxaban tosylate for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (Report)
Greenhalgh, J., Longworth, L., Crossan, C., Singh, J., Bagust, A., Boland, A., . . . Hall, M. (2015). Edoxaban tosylate for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation: Edoxaban tosylate for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (14/14/01). NICE website. Retrieved from https://www.nice.org.uk/
Greenhalgh, J., Bagust, A., Boland, A., Dwan, K., Beale, S., Hockenhull, J., . . . Marshall, E. (2015). Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation. HEALTH TECHNOLOGY ASSESSMENT, 19(47), I-133. doi:10.3310/hta19470DOI: 10.3310/hta19470
Protogerou, C., Fleernan, N., Dwan, K., Richardson, M., Dundar, Y., & Hagger, M. S. (2015). Moderators of the effect of psychological interventions on depression and anxiety in cardiac surgery patients: A systematic review and meta-analysis. BEHAVIOUR RESEARCH AND THERAPY, 73, 151-164. doi:10.1016/j.brat.2015.08.004DOI: 10.1016/j.brat.2015.08.004
Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis (Journal article)
Greenhalgh, J., Bagust, A., Boland, A., Dwan, K., Beale, S., Fleeman, N., . . . Fisher, M. (2015). Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis. HEALTH TECHNOLOGY ASSESSMENT, 19(29), 1-+. doi:10.3310/hta19290DOI: 10.3310/hta19290
2014
The diagnostic accuracy of the GenoType® MTBDR<i>sl</i> assay for the detection of resistance to second-line anti-tuberculosis drugs (Journal article)
Theron, G., Peter, J., Richardson, M., Barnard, M., Donegan, S., Warren, R., . . . Dheda, K. (2014). The diagnostic accuracy of the GenoType® MTBDR<i>sl</i> assay for the detection of resistance to second-line anti-tuberculosis drugs. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (10). doi:10.1002/14651858.CD010705.pub2DOI: 10.1002/14651858.CD010705.pub2
Fleeman, N., Bagust, A., Boland, A., Dwan, K., Chaplin, M., Beale, S., . . . Greystoke, A. (2014). Nintedanib for previously treated locally advanced or metastatic non small cell lung cancer: Nintedanib for previously treated locally advanced or metastatic non-small cell lung cancer (13/106/01). NICE Website. Retrieved from https://www.nice.org.uk/
Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism (Report)
Greenhalgh, J., Bagust, A., Beale, S., Boland, A., Chaplin, M., Dwan, K., . . . Hall, M. (2014). Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism: Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism (14/15/01). NICE website. Retrieved from https://www.nice.org.uk/
Dabrafenib for treating unresectable, advanced or metastatic BRAFv600 mutation- positive melanoma (Report)
Fleeman, N., Bagust, A., Beale, S., Boland, A., Dickson, R., Dwan, K., . . . Banks, L. (2014). Dabrafenib for treating unresectable, advanced or metastatic BRAFv600 mutation- positive melanoma: Dabrafenib for treating unresectable, advanced or metastatic BRAFv600 mutation- positive melanoma (12/54). NICE Website. Retrieved from https://www.nice.org.uk/guidance/ta321/history
EFFICACY OF PSYCHOLOGICAL INTERVENTIONS TO REDUCE DISTRESS IN PATIENTS UNDERGOING INVASIVE CARDIAC PROCEDURES: A META-ANALYSIS (Conference Paper)
Protogerou, C., Fleeman, N. F., Dwain, K. D., Richardson, M. R., Dundar, Y. D., & Dickson, R. D. (2014). EFFICACY OF PSYCHOLOGICAL INTERVENTIONS TO REDUCE DISTRESS IN PATIENTS UNDERGOING INVASIVE CARDIAC PROCEDURES: A META-ANALYSIS. In INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE Vol. 21 (pp. S63). Retrieved from https://www.webofscience.com/
